Cargando…

Gut microbiota is associated with response to (131)I therapy in patients with papillary thyroid carcinoma

PURPOSE: Radioactive iodine ((131)I) therapy is a conventional post-surgery treatment widely used for papillary thyroid carcinoma (PTC). Since (131)I is orally administered, we hypothesize that it may affect gut microbiome. This study aims to investigate alterations of intestinal microbiome caused b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Lei, Zhang, Linjing, Tang, Li, Huang, Dingde, Pan, Deng, Guo, Wei, He, Song, Huang, Yong, Chen, Yu, Xiao, Xu, Tang, Bo, Chen, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027784/ https://www.ncbi.nlm.nih.gov/pubmed/36512067 http://dx.doi.org/10.1007/s00259-022-06072-5

Ejemplares similares

I(131) Accumulation in Hydrocele in the Setting of Metastatic Papillary Carcinoma Thyroid
por: Seetharam, SJ, et al.
Publicado: (2022)

Analysis of factors influencing the clinical outcome after surgery and (131)I therapy in patients with moderate-risk thyroid papillary carcinoma
por: Li, Yixuan, et al.
Publicado: (2022)

Clinical Analysis of the Short-Term Outcome of Papillary Thyroid Micro Carcinoma After (131)I Treatment
por: Cao, Jingjia, et al.
Publicado: (2021)

Changes of Regulatory T and B Cells in Patients with Papillary Thyroid Carcinoma after (131)I Radioablation: A Preliminary Study
por: Jiang, Lei, et al.
Publicado: (2013)

Induction of Leukaemia by (131)I Treatment of Thyroid Carcinoma
por: Brincker, H., et al.
Publicado: (1973)

Hiatal hernia uptake of iodine-131 mimicking mediastinal metastasis of papillary thyroid carcinoma
por: Haghighatafshar, Mahdi, et al.
Publicado: (2015)

AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND
por: Blažeković, Ivan, et al.
Publicado: (2018)

Unfavorable efficacy to (131)I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb
por: Zhang, Na, et al.
Publicado: (2017)

Preliminary Study on the Relationship of BRAF Mutations with the Outcome of the First (131)I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma
por: Shangguan, Linjue, et al.
Publicado: (2021)

Is (131)I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
por: Rosario, Pedro Weslley, et al.
Publicado: (2016)

The Molecular Effect of Diagnostic Absorbed Doses from (131)I on Papillary Thyroid Cancer Cells In Vitro
por: Stasiołek, Mariusz, et al.
Publicado: (2017)

Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-(131)I-avid lung metastases
por: Song*, Hong-Jun, et al.
Publicado: (2013)

Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before (131)I therapy based on clinical and ultrasound characteristics
por: Yu, Fei, et al.
Publicado: (2023)

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
por: Li, Wanting, et al.
Publicado: (2023)

Synchronous papillary thyroid carcinoma and breast ductal carcinoma
por: Kong, Heng, et al.
Publicado: (2020)

Advances in Antioxidant Applications for Combating (131)I Side Effects in Thyroid Cancer Treatment
por: Yang, Li, et al.
Publicado: (2023)

LncRNA-SLC6A9-5:2: a potent sensitizer in (131)I-resistant papillary thyroid carcinoma with PARP-1 induction
por: Xiang, Cheng, et al.
Publicado: (2017)

Efficacy and Affecting Factors of (131)I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
por: Wang, Chen, et al.
Publicado: (2018)

lncRNA CASC2 Enhances (131)I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155
por: Tao, Ling, et al.
Publicado: (2020)

Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma
por: Oral, Aylin, et al.
Publicado: (2018)

SAT-LB097 The Effect of (131)I Treatment on Pregnancy Outcomes after Thyroidectomy in Patients with Differentiated Thyroid Carcinoma: A Meta-Analysis
por: Zhang, Lijuan, et al.
Publicado: (2019)

Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto(’)s Thyroiditis： ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma
por: Zeng, Chao, et al.
Publicado: (2022)

False-positive I-131 Uptakes at Pulmonary Wedge-resection Site and Soft Tissue Lateral to the Femoral Heads in a Patient with Papillary Thyroid Carcinoma
por: Yazıcı, Bülent, et al.
Publicado: (2019)

Diagnostic Performance of (18)F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative (131)I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level
por: Qiu, Zhong-Ling, et al.
Publicado: (2017)

Analysis of the incidence and influencing factors of hyponatremia before (131)I treatment of differentiated thyroid carcinoma
por: Cao, Jing-Jia, et al.
Publicado: (2021)

A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period
por: Murayama, Daisuke, et al.
Publicado: (2021)

Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis
por: Tang, Qizhi, et al.
Publicado: (2022)

Renal Metastasis and Dual ((18)F-Fluorodeoxyglucose and (131)I) Avid Skeletal Metastasis in a Patient with Papillary Thyroid Cancer
por: Kulkarni, Prashanth, et al.
Publicado: (2017)

Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma
por: Palaniswamy, Shanmuga S., et al.
Publicado: (2018)

Global Hotspots and Prospects of I-131 Therapy in Thyroid Carcinoma via Bibliometric Analysis
por: Lin, Shang, et al.
Publicado: (2021)

Normalization of lymphocyte count after high ablative dose of I-131 in a patient with chronic lymphoid leukemia and secondary papillary carcinoma of the thyroid. Case report
por: Thom, Anneliese Rosmarie Gertrud Fischer, et al.
Publicado: (2014)

A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
por: Hao, Jie, et al.
Publicado: (2023)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Predictive factors and prognosis for recurrent laryngeal nerve invasion in papillary thyroid carcinoma
por: Chen, Wenjie, et al.
Publicado: (2017)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Transcriptional response to (131)I exposure of rat thyroid gland
por: Rudqvist, Nils, et al.
Publicado: (2017)

Identification of a 3-Gene Prognostic Index for Papillary Thyroid Carcinoma
por: Zhong, Lin-Kun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_va83nrld4qtufuv59vd75dcqpg